Working to Eradicate Gynecologic Cancers

328
Utilizing camelid-derived single domain antibodies to enhance immunotherapy of ovarian cancer

Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)
E. A. van Erp1, L. N. Kaliberova1, S. A. Kaliberov1, E. D. Thomas2, K. S. Bevis2, R. D. Alvarez2 and D. T. Curiel3
1Washington University School of Medicine, St Louis, MO, 2University of Alabama at Birmingham, Birmingham, AL, 3Washington University School of Medicine, St. Louis, MO
 
 
See more of: Poster Session A
See more of: Poster Session
<< Previous Presentation | Next Presentation >>